Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0205-2026Class II

Product: STA Liatest D-Di; REF: 00515

Diagnostica Stago, Inc. / initiated 2025-09-12 / Open, Classified

Diagnostica Stago, Inc. began a recall of Product: STA Liatest D-Di; REF: 00515 on . FDA classified it as Class II and gives the reason as "A potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-0205-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Diagnostica Stago, Inc.
Product
Product: STA Liatest D-Di; REF: 00515;
Product code
DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Reason for recall
A potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots.
FDA root cause
Under Investigation by firm
Action
On September 12, 2025 URGENT: MEDICAL DEVICE RECALL (REMOVAL) letters were emailed to customers. Actions for customers: Discontinue use of affected lots and dispose of them in accordance with your local regulations. Complete and return response form. For additional information, please contact Stago's 24/7 Hotline at 1-800-725-0607.
Quantity in commerce
12740 units
Distribution
Worldwide distribution- US Nationwide and the country of Canada.
Product codes and lots
REF: 00515; UDI-DI: 03607450005158; Lot numbers: 271382, 271411; Expiration 09/30/2025;

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0205-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0205-2026Class IIOngoingVoluntary: Firm initiated